Induction of p21(WAF1) expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells

Oncogene

Volumn 19, Issue 33, 2000, Pages 3766-3773

  Lee, Te Hsiu ^a   Chuang, Lea Yea ^a   Hung, Wen Chun ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Estrogen receptor; p21(WAF1); Protein kinase A; Tamoxifen

Indexed keywords

BUCLADESINE; CALPHOSTIN C; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; ESTROGEN RECEPTOR; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C; PROTEIN P21; TAMOXIFEN; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; ANTIESTROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DNA BINDING PROTEIN; LUCIFERASE; NUCLEAR PROTEIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SP3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; CELL PROLIFERATION; DNA BINDING; GENE DELETION; GENE EXPRESSION REGULATION; GENE MAPPING; HUMAN; HUMAN CELL; LUNG CANCER; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; BINDING SITE; CELL CULTURE; DNA RESPONSIVE ELEMENT; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; LUNG TUMOR; METABOLISM; MUTAGENESIS; PROMOTER REGION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, HORMONAL; BINDING SITES; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; ESTROGEN ANTAGONISTS; GENE EXPRESSION; HUMANS; LUCIFERASES; LUNG NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASES; MUTAGENESIS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TAMOXIFEN; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034601297     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203715     Document Type: Article

References (48)

1. Ahlgren R, Suske G, Waterman MR and Lund J. (1999). J. Biol. Chem., 274, 19422-19428.
2. Andrew NC and Faller DV. (1991). Nuc. Acids Res., 19, 6418-6419.
3. Armstrong SA, Barry DA, Leggett RW and Mueller CR. (1997). J. Biol. Chem., 272, 13489-13495.
4. Azizkhan JC, Jensen DE, Pierce AJ and Wade M. (1993). Crit. Rev. Eukaryotic Gene Exp., 3, 229-254.
5. Bennett W, El-Deiry WS, Rush WL, Guinee DG, Freedman AN, Caporaso NE, Welsh JA, Jones RT, Borkowski A, Travis WD, Fleming MV, Trastek V, Pairolero PC, Tazelaar HD, Midthun D, Jett JR, Liotta LA and Harris CC. (1998). Clin. Cancer Res., 4, 1499-1506.
6. Biggs JR, Kudlow JE and Kraft AS. (1996). J. Biol. Chem., 271, 901-906.
7. Billon N, van Grunsven LA and Rudkin BB. (1999). Oncogene, 13, 2047-2054.
8. Caputi M, Esposito V, Baldi A, Luca AD, Dean C, Signoriello G, Baldi F and Giodano A. (1998). Am. J. Respir. Cell Mol. Biol., 18, 213-217.
9. Cass LA, Summers SA, Prendergast GV, Backer JM, Birnbaum MJ and Meinkoth JL. (1999). Mol. Cell. Biol., 19, 5882-5891.
10. Catzaveles C, Tsao MS, DeBoer G, Bhattacharya N, Shepherd FA and Slingerland JM. (1999). Cancer Res., 59, 684-688.
11. Chin YE, Kitagawa M, Su WCS, You ZH, Iwamoto Y and Fu XY. (1996). Science, 272, 719-722.
12. Chinery R, Broekman J, Peeler MO, Shyr Y, Beauchamp RD and Coffey RJ. (1997). Nature Med., 3, 1233-1241.
13. Cobb MH and Goddsmith EJ. (1995). J. Biol. Chem., 270, 14843-14846.
14. Couldwell WT, Weiss MH, DeGiorgia CM, Weiner LP, Hinton DR, Ehresmann GR, Conti PS and Apuzzo ML. (1993). Neurosurgery, 32, 485-489.
15. Cram EJ, Ramos RA, Wang EC, Cha HH, Nishio Y and Firestone GL. (1998). J. Biol. Chem., 273, 2008-2014.
16. Croxtall JD, Emmas C, White JO, Choudhary Q and Flower RJ. (1994). Biochem. Pharmacol., 47, 197-202.
17. Daniel S, Zhang S, DePaoli-Roach AA and Kim KH. (1996). J. Biol. Chem., 271, 14692-14697.
18. Datto MB, Yu Y and Wang XF. (1995). J. Biol. Chem., 270, 28623-28628.
19. DelPrete SA, Maurer LH, O'Donnel J, Forcier JR and LeMarbre P. (1984). Cancer Treat. Rep., 68, 1403-1405.
20. Duhl JL, Yu R, Jiao JJ, Matwyshyn GA, Li W, Tan TH and Tony Kong AN. (1997). Pharma. Res., 14, 186-189.
21. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E And Wolmark N. (1998). J. Natl. Cancer Inst., 90, 1371-1388.
22. Furr BJA and Jordan VC. (1984). Pharmacol. Ther., 25, 127-205.
23. Gupta S, Campbell D, Derijard T and Davis RJ. (1995). Science, 267, 389-393.
24. Henderson BE, Ross RK and Pike MC. (1992). Science, 259, 633-638.
25. Ip YT and Davis RJ. (1998). Curr. Opin. Cell Biol., 10, 205-219.
26. Jackson SP, MacDonald JJ, Lees-Miller S and Tijan R. (1990). Cell, 63, 155-165.
27. Jordan VC and Murphy CS. (1990). Endocrin. Rev., 11, 578-610.
28. Jordan VC, Lababadi MK and Fakhey SL. (1991). J. Natl. Cancer Inst., 83, 492-496.
29. Komiya T, Hosono Y, Hirashima T, Masuda N, Yasumitsu T, Nakagawa K, Kikui M, Ohno A, Fukuoka M and Kawase I. (1997). Clin. Cancer Res., 3, 1831-1835.
30. Lee SJ, Ha MJ, Lee J, Nguyen PM, Choi YH, Pirnia F, Kang WK, Wang XF, Kim SJ and Trepel JB. (1998). J. Biol. Chem., 273, 10618-10623.
31. Lee TH, Chuang LY and Hung WC. (1999). Oncogene, 18, 4269-4274.
32. Liu M, Iavarone A and Freedman LP. (1996). J. Biol. Chem., 271, 31723-31728.
33. Livneh E and Fishman DD. (1997). Eur. J. Biochem., 248, 1-9.
34. Marais R, Wynne J and Treisman R. (1993). Cell, 73, 381-393.
35. Menard S, Aiello P, Tagliabue E, Rumio C, Lollini PL, Colnaghi MI and Balsari A. (2000). Cancer Res., 60, 273-275.
36. Merchant JL, Du M and Todisco A. (1999). Biochem. Biophys. Res. Commun., 254, 454-461.
37. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, Fujita T, Ohtani-Fujita N, Matsukawa Y, Tokino T, Yamagishi H, Oka T, Nomura H and Sakai T. (1997). J. Biol. Chem., 272, 22199-22206.
38. O'Brian CA, Liskkamp RM, Solomon DH and Weinstein IB. (1986). J. Natl. Cancer Inst., 76, 1243-1246.
39. Owen GI, Richer JK, Tung L, Takimoto G and Horwitz KB. (1998). J. Biol. Chem., 273, 10696-10701.
40. Prowse DM, Bolgan L, Molnar A and Dotto GP. (1997). J. Biol. Chem., 272, 1308-1314.
41. Rao S, Gray-Bablin J, Herliczek TW and Keyomarsi K. (1999). Exp. Cell Res., 252, 211-223.
42. Robinson EK, Grau AM, Evans DB, Smid CM, Chiao PJ, Abbruzzese JL and Grimm FA. (1998). Ann. Surg. Oncol., 5, 342-349.
43. Rohlff C, Ahmad S, Borelini F, Lei J and Glazer RJ. (1997). J. Biol. Chem., 272, 21137-21141.
44. Rohlff C, Blagoskonny MV, Kyle E, Kesari A, Kim IY, Zelner DJ, Hakim F, Trepel J and Bergan RC. (1998). Prostate, 37, 51-59.
45. Rowlands MG, Parr IB, McCaque R, Jarman M and Goddard PM. (1990). Biochem. Pharmacol., 40, 283-289.
46. White LA, Reeben M, Saarma M and Whittemore SR. (1997). J. Neuro. Res., 47, 242-252.
47. Yatabe Y, Masuda A, Koshikawa T, Nakamura S, Kuroishi T, Osada H, Takahashi T, Mitsudomi T and Takahashi T. (1998). Cancer Res., 58, 1042-1047.
48. Zeng YX, Somasundaram K and El-Deiry WS. (1997). Nat. Genet., 15, 78-82.